LIFE Stock Recent News

MCKINNEY, Texas , Feb. 27, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has raised the quarterly dividend to $.2700 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company's transfer agent on April 3, 2025. The dividend will be paid on May 1, 2025.

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) -  DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to announce that it is arranging a private placement of a minimum of $350,000 and a maximum of $510,000 of units (each, a "Unit"), at a price of $0.03 per Unit; (the "Offering"). The Offering is being led by EMD Financial Inc. Each Unit will be comprised of one common share ("Common Share") in the capital of the Company and one (1) Common Share purchase warrant ("Warrant") of the Company.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network of nurses, doctors, and pharmacy distribution, is pleased to announce that, further to the news releases of the Company dated February 10, 2025, and February 18, 2025, it has closed its previously announced commercially reasonable “best efforts” private placement with Beacon Securities Limited (the "Agent") acting as the sole agent. The Company issued 3,492,300 units of the Company (each, a "Unit") at a price of $1.55 per Unit for aggregate gross proceeds of $5,413,065 (the “Offering”).

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -

THOUSAND OAKS, Calif. , Feb. 7, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 35th Annual Oppenheimer Healthcare Life Sciences Conference at 11:20 a.m.

MCKINNEY, Texas , Feb. 5, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended December 31, 2024, net income was $3.01 per diluted common share, compared with $2.88 per diluted common share for the year-ago quarter. Net operating income for the quarter was $3.14 per diluted common share, compared with $2.80 per diluted common share for the year-ago quarter.

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Trilogy AI Corp. (CSE: TRAI) (OTCQB: TRAIF) (FSE: Y92)  (formerly, Ambari Brands Inc.) (the "Company") is pleased to announce, further to its press release dated December 16, 2024, that the Company has closed its non-brokered private placement financing (the "LIFE Offering") of 6,826,667 common shares (the "Common Shares") at C$0.07 per Common Share, for aggregate gross proceeds of approximately C$477,866.69. The Company has also closed its concurrent private placement financing (the "Private Placement") of 5,174,240 common shares (the "Private Placement Shares") at C$0.07 per Private Placement Share for aggregate gross proceeds of approximately C$362,196.82, and its private placement offering of Common Share purchase warrants (the "Warrant Offering" and together with the LIFE Offering and the Private Placement, the "Offerings"), issuing a total of 9,311,500 warrants (the "Warrants"), at a price of C$0.05 per Warrant f

Oslo, Norway and Tokyo, Japan - 27 January 2025 – IDEX Biometrics enters a new market, together with LIFE CARD, Japan's most innovative credit card issuer. This marks the market introduction of biometric payment cards in Japan. LIFE CARD is targeting commercial deployment in the first half of 2025.